Endocyte, Inc. (ECYT) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 05/24/2016 1 month $3.77 $3.91 +3.71% -3 Active
Comments: Deadman Floating. High Risk
NSTRASH NSTRASH 10/03/2014 1 Year $5.97 $4.69 -21.44% -21 Ended
Comments: increasing revenue over 3yrs
ballchinnian5 ballchinnian5 04/10/2014 1 Year $20.91 $6.18 -70.44% -70 Ended
Comments: Probable blockbuster drug
InvestorsXpress InvestorsXpress 03/21/2014 1 day $14.64 $27.22 +85.93% 85 Ended
Comments: FDA Approval Expected $$$$
jnlimbachia jnlimbachia 03/18/2014 3 months $14.60 $7.00 -52.05% -52 Ended
richardod richardod 02/19/2013 3 months $9.74 $14.38 +47.64% 47 Ended

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.